Carl Stubbings
Follow
Get notifications in MyBN when activity occurs.
Carl Stubbings
Chief Operating Officer / INOVIQ
Carl Stubbings has over 30 years’ experience in the health sector with a focus on medical diagnostics as well as biotechnology. Mr Stubbings specialised in sales, with a particular emphasis on marketing, across North America, Latin America, Asia Pacific and Europe.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 291st | INOVIQ | 33% | 109% |
| 703rd | Frugl Group | 0% | -20% |
| 766th | Advanced Health Intelligence | -2% | -24% |
| 1615th | Nanollose | -60% | -21% |
| 1865th | Invex Therapeutics | -83% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 157th |  | INOVIQ | $1.6m |
| 172nd | | Frugl Group | $806k |
| 173rd | | Advanced Health Intelligence | $772k |
| 175th |  | Invex Therapeutics | $459k |
| 176th |  | Nanollose | $412k |
202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Chief Business Officer, Benitec | 03 Aug 2020 |
| NEW ROLE: Managing Director, Chief Executive, Sienna Cancer Diagnostics | 03 Aug 2020 |
| NEW ROLE: Non-Executive Director, Sienna Cancer Diagnostics | 03 Aug 2020 |
| NEW ROLE: Chief Operating Officer, INOVIQ | 03 Aug 2020 |
